Investors / Japan / Keio Innovation Initiative
Keio Innovation Initiative
Venture capital · Tokyo, Japan · Asia Pacific
Keio Innovation Initiative is a venture capital firm that invests in research-based startups originating from university laboratories, helping them grow into businesses. It manages three funds and describes itself as a bridge between academia and business, supporting portfolio companies from the seed stage through post-IPO management.
Invests inHealthcare & BiotechAI & Machine Learning
In its own wordsdeep techimpact investinguniversity spinoutshealthcareacademia
Your fit with Keio Innovation Initiative
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsKeio Innovation Initiative lists 40 checked portfolio companies on its own site and is named in 6 funding rounds, 1 of them as lead. Its most frequent entry is Series A, 67% of the companies with a known first round. Its largest themes are Healthcare & Biotech (36%), AI & Machine Learning (18%) and Industrial & Manufacturing (13%). 95% of its companies are based in Japan. It invests most often alongside Global Brain, Spiral Capital and DBJ Capital.
Counts come from funding rounds that name Keio Innovation Initiative, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Keio Innovation Initiative's whole history. Rounds on record name 6 companies; its own site lists 40. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 17% |
| Series A | 67% |
| Series B | 17% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 3 | 0 |
| '26 | 3 | 1 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 77th | 40 companies |
| Recent activity | 76th | 3 rounds in 12 months |
| Early stage | 57th | 17% of entries at pre-seed or seed |
| Evidence | 56th | 3% of companies confirmed by a round |
| Sector focus | 66th | 36% in its largest sector |
| Reach | 42th | 2 countries |
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 36% | 15% |
| AI & Machine Learning | 18% | 18% |
| Industrial & Manufacturing | 13% | 7% |
| Education | 9% | 7% |
| Space & Defense | 4% | 3% |
| Climate & Energy | 4% | 1% |
| Enterprise Software | 4% | 8% |
| Human Resources | 4% | 1% |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Global Brain | 9 |
| Spiral Capital | 5 |
| DBJ Capital | 4 |
| JAFCO | 4 |
| OSAKA University Venture Capital | 4 |
| SMBC Venture Capital | 4 |
| Beyond Next Ventures | 3 |
| JIC Venture Growth Investments | 3 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers40100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Co-investor network
who it backs companies with, and who they back togetherCompare Keio Innovation Initiative head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Keio Innovation Initiative| Date | Company | Stage |
|---|---|---|
| 15 Jul 2026 | Series A | |
| 19 Mar 2026 | Series A | |
| 15 Oct 2025 | Seed | |
| 24 Sept 2025 | Series A | |
| 8 Sept 2025 | Series B |
Round details for Keio Innovation Initiative
Amounts, full round histories and every co-investor in Keio Innovation Initiative's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
40 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| AdipoSeeds develops a technology to cultivate blood platelets from fat cells without complex and costly gene introduction, aiming to address the global shortage of blood platelets. | Healthcare & Biotech | Portfolio page | ||
| The company develops and provides an application for measuring and managing employees' physical and mental health | Healthcare & BiotechEnterprise Software | Portfolio page | ||
| Bdot Medical is a medical equipment manufacturer that aims to promote the spread of proton cancer therapy | Healthcare & Biotech | Portfolio page | ||
| Cuebus develops and implements linear motor-based robot warehouses | Industrial & Manufacturing | Portfolio page | ||
| CureApp develops medical treatment apps based on medical evidence to solve healthcare issues and provide high-quality treatment to all people. | Healthcare & Biotech | Portfolio page | ||
| The company develops and provides technology to improve pig farming and create a sustainable pork ecosystem | AI & Machine LearningAI & Machine Learning | Portfolio page | ||
| EXORPHIA is a biotechnology company that develops and engineers extracellular vesicles for use in assisted reproductive technology and pharmaceutical applications | Healthcare & Biotech | Portfolio page | ||
| The company develops innovative eye treatment drugs, including a preventive drug for retinopathy of prematurity | Healthcare & Biotech | Portfolio page | ||
| Fermecutes, Inc. produces and provides protein sources from natto bacteria to contribute to solving food problems. | Food & Agriculture | Portfolio page | ||
| FingerVision develops and implements tactile sensing technology to enhance the capabilities of robots and machines | Robotics & HardwareAI & Machine Learning | Portfolio page | ||
| The company develops artificial intelligence, including a product called GS8 | AI & Machine LearningCybersecurity | Portfolio page | ||
| The company develops wearable devices to measure lactate levels in sweat, providing physiological data for healthcare and sports applications. | Healthcare & Biotech | Portfolio page | ||
| Heartseed Inc. develops and delivers cardiac regenerative medicine to treat severe heart failure. | Healthcare & Biotech | Portfolio page | ||
| Helical Fusion develops and utilizes helical-type nuclear fusion reactors to achieve sustainable and stable energy production. | EducationIndustrial & Manufacturing | Portfolio page | ||
| Himuka AM Pharma develops and conducts clinical trials for pharmaceutical products such as HM101 and HM201. | Healthcare & Biotech | Portfolio page | ||
| The company provides various services including assessment and education tools for individuals and organizations. | EducationHuman Resources | Portfolio page | ||
| JCCL develops and implements CO₂ capture and recycling technology to create a carbon-neutral society. | Climate & Energy | Portfolio page | ||
| The company provides services including an epilepsy seizure recording app and online medical services for patients with epilepsy and their families. | Healthcare & Biotech | Portfolio page | ||
| The company conducts research and development of pharmaceuticals and regenerative medicine using iPS cell technology | Healthcare & Biotech | Portfolio page | ||
| Kringle Pharma is a late-stage regenerative medicine bioventure that conducts clinical trials for various intractable diseases, including rare diseases, using HGF protein | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- keio-innovation.co.jp
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 8 Sept 2025
- Companies checked
- 40
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Keio Innovation Initiative's profile as data
Pull Keio Innovation Initiative's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/keio-innovation.co.jp
# also
GET /v1/firms/keio-innovation.co.jp/portfolio
GET /v1/firms/keio-innovation.co.jp/coinvestors
GET /v1/firms/keio-innovation.co.jp/news